secwatch.observer — SEC 8-K summary
======================================

Issuer:     ClearPoint Neuro, Inc. (CLPT)
CIK:        0001285550
Form:       8-K
Filed at:   2026-01-12T23:59:59+00:00
Accession:  0001193125-26-009867
Event type: earnings
Sentiment:  positive
Materiality: 0.75
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

ClearPoint Neuro Q4 2025 prelim revenue $10.4M (+20% YoY); FY2026 guidance $54-60M
--------------------------------------------------------------------------------

- Q4 2025 preliminary unaudited revenue ~$10.4M, 20% comparable sales growth over Q4 2024, excluding recent IRRA flow acquisition.
- Full year 2025 preliminary revenue ~$37M.
- FY2026 revenue guided at $54-60M, driven by organic growth and IRRA flow product integration.
- Q4 segment growth: functional neurosurgery disposables +23%, biologics/drug delivery +26%.
- Preliminary results subject to revision; audited results expected later in Q1 2026.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1285550/000119312526009867/0001193125-26-009867-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1285550/000119312526009867/clpt-20260112.htm
  HTML page:      https://secwatch.observer/filing/0001193125-26-009867

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer